{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:58:50Z","timestamp":1782403130419,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Rotary Club of Belmont, W.A"},{"name":"Australian Rotary Health Research Fund"},{"DOI":"10.13039\/501100001797","name":"Curtin University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001797","id-type":"DOI","asserted-by":"crossref"}]},{"name":"School of Biomedical Sciences (Curtin University)"},{"name":"Commercialisation Advisory Board of Curtin University"},{"name":"Cancer Council, WA"},{"name":"Actinogen Ltd, Perth"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.yexcr.2016.02.008","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T18:33:59Z","timestamp":1454956439000},"page":"218-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells"],"prefix":"10.1016","volume":"341","author":[{"given":"Vanathi","family":"Perumal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Arfuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Newsholme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Dharmarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2016.02.008_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ctrv.2011.01.001","article-title":"Advances in the biology of malignant pleural mesothelioma","volume":"37","author":"Zucali","year":"2011","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.yexcr.2016.02.008_bib2","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1038\/sj.onc.1207881","article-title":"Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma","volume":"23","author":"Lee","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2016.02.008_bib3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.bbrc.2004.09.001","article-title":"Dickkopf\u22121 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma","volume":"323","author":"Lee","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2016.02.008_bib4","first-page":"423","article-title":"Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma","volume":"24","author":"Kohno","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2016.02.008_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1158\/0008-5472.743.65.3","article-title":"Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells","volume":"65","author":"He","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2016.02.008_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2013.09.025","article-title":"Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells","volume":"440","author":"Fox","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2016.02.008_bib7","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2741\/1953","article-title":"WNT signaling in malignant mesothelioma","volume":"11","author":"Fox","year":"2006","journal-title":"Front. Biosci."},{"key":"10.1016\/j.yexcr.2016.02.008_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-2187-3-10","article-title":"SFRP-4 abrogates Wnt\u22123a-induced beta-catenin and Akt\/PKB signalling and reverses a Wnt\u22123a-imposed inhibition of in vitro mammary differentiation","volume":"3","author":"Constantinou","year":"2008","journal-title":"J. Mol. Signal."},{"key":"10.1016\/j.yexcr.2016.02.008_bib9","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2353\/ajpath.2010.090465","article-title":"Secreted frizzled-related protein 4: an angiogenesis inhibitor","volume":"176","author":"Muley","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2016.02.008_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2121-13-25","article-title":"Secreted frizzled-related protein 4 expression is positively associated with responsiveness to cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers","volume":"13","author":"Saran","year":"2012","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.yexcr.2016.02.008_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/096504012X13425470196010","article-title":"The role of the cysteine-rich domain and netrin-like domain of secreted frizzled-related protein 4 in angiogenesis inhibition in vitro","volume":"20","author":"Longman","year":"2012","journal-title":"Oncol. Res."},{"key":"10.1016\/j.yexcr.2016.02.008_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2016.02.008_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/1389200216666150602145145","article-title":"Glucose Addiction in Cancer Therapy: Advances and Drawbacks","volume":"16","author":"Granja","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.yexcr.2016.02.008_bib14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer cell metabolism: one hallmark, many faces","volume":"2","author":"Cantor","year":"2012","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.yexcr.2016.02.008_bib15","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.diabres.2007.01.033","article-title":"The role of GSK3 in glucose homeostasis and the development of insulin resistance","volume":"77","author":"Lee","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.yexcr.2016.02.008_bib16","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1038\/cddis.2014.264","article-title":"Nitric oxide is a positive regulator of the Warburg effect in ovarian cancer cells","volume":"5","author":"Caneba","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2016.02.008_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.2910470219","article-title":"Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions","volume":"47","author":"Manning","year":"1991","journal-title":"Int. J. cancer"},{"key":"10.1016\/j.yexcr.2016.02.008_bib18","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1016\/j.bmc.2011.10.037","article-title":"Synthesis and antimalarial evaluation of novel isocryptolepine derivatives","volume":"19","author":"Whittell","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.yexcr.2016.02.008_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.btre.2015.04.004","article-title":"Validation of threee viable-cell counting methods: Manual, semi-automated, and automated","volume":"7","author":"Cadena-Herrera","year":"2015","journal-title":"Biotechnol. Rep."},{"key":"10.1016\/j.yexcr.2016.02.008_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/ac010822u","article-title":"Design and characterization of immobilized enzymes in microfluidic systems","volume":"74","author":"Mao","year":"2002","journal-title":"Anal. Chem."},{"key":"10.1016\/j.yexcr.2016.02.008_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3727\/096504013X13786659070154","article-title":"Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells","volume":"21","author":"Warrier","year":"2013","journal-title":"Oncol. Res."},{"key":"10.1016\/j.yexcr.2016.02.008_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cgt.2014.42","article-title":"Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition","volume":"21","author":"Warrier","year":"2014","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.yexcr.2016.02.008_bib23","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1038\/srep15649","article-title":"Metabolic profiling reveals potential metabolic markers associated with Hypoxia Inducible Factor-mediated signalling in hypoxic cancer cells","volume":"5","author":"Armitage","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2016.02.008_bib24","doi-asserted-by":"crossref","first-page":"28104","DOI":"10.18632\/oncotarget.4612","article-title":"HIF isoforms have divergent effects on invasion, metastasis,\u00a0metabolism and formation of lipid droplets","volume":"6","author":"Shah","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2016.02.008_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2015.10.027","article-title":"Metabolic exchanges within tumor microenvironment","author":"Chiarugi","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2016.02.008_bib26","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1158\/0008-5472.CAN-13-3383","article-title":"Mitochondrial retrograde signaling mediated by UCP2 inhibits cancer cell proliferation and tumorigenesis","volume":"74","author":"Esteves","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2016.02.008_bib27","article-title":"Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells","author":"Kahlert","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2016.02.008_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cmet.2012.10.009","article-title":"Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes","volume":"16","author":"Mahdi","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.yexcr.2016.02.008_bib29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1507\/endocrj.EJ15-0212","article-title":"Relationship between serum secreted frizzled-related protein 4 levels and the first-phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance","volume":"62","author":"Liu","year":"2015","journal-title":"Endocr. J"},{"key":"10.1016\/j.yexcr.2016.02.008_bib30","doi-asserted-by":"crossref","first-page":"e78320","DOI":"10.1371\/journal.pone.0078320","article-title":"Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolism, and enhanced macrophage infiltration","volume":"8","author":"Gauger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2016.02.008_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0167-4781(97)00025-0","article-title":"Nuclear genes for cytochrome c oxidase","volume":"1352","author":"Grossman","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2016.02.008_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0891-5849(00)00305-1","article-title":"Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase","volume":"29","author":"Kadenbach","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.yexcr.2016.02.008_bib33","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.18632\/oncotarget.3015","article-title":"Nuclear-encoded cytochrome c oxidase subunit 4 regulates BMI1 expression and determines proliferative capacity of high-grade gliomas","volume":"6","author":"Oliva","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2016.02.008_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0006-8993(01)03005-0","article-title":"Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium","volume":"919","author":"King","year":"2001","journal-title":"Brain Res."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482716300283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482716300283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T20:09:41Z","timestamp":1692216581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482716300283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0014482716300283"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2016.02.008","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2016.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}